PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.\', \'Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.\', \'Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.\', \'Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.\', \'Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.\', \'Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.675679
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33995420
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all